Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
The adenosine pathway is an exciting new target in the field of cancer immunotherapy. CD73 is the main producer of extracellular adenosine. Non-small cell lung cancer (NSCLC) has one of the highest CD73 expression signatures among all cancer types and the presence of common oncogenic drivers of NSCL...
Main Authors: | Ryan R. Kowash, Esra A. Akbay |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1130358/full |
Similar Items
-
Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
by: Zoya Kurago, et al.
Published: (2023-06-01) -
The Immune Regulatory Role of Adenosine in the Tumor Microenvironment
by: Jianlei Xing, et al.
Published: (2023-10-01) -
A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer
by: Emily Maria Ploeg, et al.
Published: (2023-07-01) -
Abnormal adenosine metabolism of neutrophils inhibits airway inflammation and remodeling in asthma model induced by Aspergillus fumigatus
by: Ting-ting Liu, et al.
Published: (2023-07-01) -
Estrogen downregulates CD73/adenosine axis hyperactivity via adaptive modulation PI3K/Akt signaling to prevent myocarditis and arrhythmias during chronic catecholamines stress
by: Marie Louise Ndzie Noah, et al.
Published: (2023-02-01)